|
|
||||||||
ANTIMICROBIAL AGENTS |





*Department of Microbiology, Porto School of Medicine, University of Porto,
Institute of Pathology and Molecular Immunology of Porto University,
Department of Gynaecology, Porto School of Medicine, University of Porto, Porto, Portugal and
Department of Obstetrics and Gynaecology, Lund University, Lund, Sweden
Corresponding author: Dr C. Pina-Vaz (email: micfam@ ip.pt).
Received 26 Aug. 1999; revised version received 24 Jan. 2000; accepted 27 Jan. 2000.
Abstract
Ibuprofen, a non-steroidal anti-inflammatory drug, exhibited antimicrobial activity against Candida albicans and non-albicans strains. At 10 mg/ml, ibuprofen showed a rapid cidal activity against exponential growth phase C. albicans, accompanied by rapid and extensive leakage of intracellular K+, permeation to propidium iodide, lysis of spheroplasts and severe membrane ultrastructural alterations. These results indicate that the killing of Candida cells is due to direct damage to the cytoplasmic membrane. At 5 mg/ml, ibuprofen inhibited growth; however, it did not kill the yeasts and did not directly affect the cytoplasmic membrane. Evaluation of yeast metabolic vitality with the fluorescent probe FUN-1 showed that growth inhibition induced by the fungistatic drug concentration was due to metabolic alterations. The combination of ibuprofen with fluconazole resulted in synergic activity with eight of the 12 Candida strains studied, including four of the five fluconazole-resistant strains. The MICs of fluconazole for the fluconazole-resistant strains decreased 2128-fold when the drug was associated with ibuprofen. When in combination with fluconazole, MICs for ibuprofen decreased by up to 64-fold for all the 12 strains studied. These results point to the practicability of using ibuprofen, alone or in combination with azoles, in the treatment of candidosis, particularly when applied topically, taking advantage of the drug's antifungal and anti-inflammatory properties.
This article has been cited by other articles:
![]() |
C. Pina-Vaz, A. G. Rodrigues, S. Costa-de-Oliveira, E. Ricardo, and P.-A. Mardh Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry J. Antimicrob. Chemother., October 1, 2005; 56(4): 678 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pina-Vaz, S. Costa-de-Oliveira, A. G. Rodrigues, and A. Espinel-Ingroff Comparison of Two Probes for Testing Susceptibilities of Pathogenic Yeasts to Voriconazole, Itraconazole, and Caspofungin by Flow Cytometry J. Clin. Microbiol., September 1, 2005; 43(9): 4674 - 4679. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canton, J. Peman, M. Gobernado, A. Viudes, and A. Espinel-Ingroff Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1593 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Pina-Vaz, S Costa-de-Oliveira, and A G Rodrigues Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16 J. Med. Microbiol., January 1, 2005; 54(1): 77 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Johnson, C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex Combination Antifungal Therapy Antimicrob. Agents Chemother., March 1, 2004; 48(3): 693 - 715. [Full Text] [PDF] |
||||
![]() |
C. Pina-Vaz, S. Costa-Oliveira, A. G. Rodrigues, and A. Salvador Novel Method Using a Laser Scanning Cytometer for Detection of Mycobacteria in Clinical Samples J. Clin. Microbiol., February 1, 2004; 42(2): 906 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. S. Alem and L. J. Douglas Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans Antimicrob. Agents Chemother., January 1, 2004; 48(1): 41 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. PINA-VAZ, F. SANSONETTY, A. G. RODRIGUES, S. COSTA-DE-OLIVEIRA, J. MARTINEZ-DE-OLIVEIRA, and A. F. FONSECA Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy J. Med. Microbiol., April 1, 2001; 50(4): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |